Cardica Inc.

Bernard A. Hausen, M.D., Ph.D. has been our President and Chief Executive Officer since December 2000. Dr. Hausen co-founded the Company in October 1997 and has served as a director and our Chief Medical Officer since inception. Dr. Hausen received a medical degree from Hannover Medical School in Germany in 1988 and was trained there as a general and cardiothoracic surgeon. Upon completion of his training, he received a Ph.D. degree in Medical Physiology in 1999. From 1996 to 2000, he was employed as a Senior Research Scientist in the Laboratory for Transplantation Immunology of the Department of Cardiothoracic Surgery at Stanford University. Until Dr. Hausen became our full-time employee in October of 2000, he remained responsible for all surgery-related research in that laboratory.

Bryan D. Knodel joined Cardica as our Vice President of Research and Development in July 2005. Since January 1998, he has been president of Bryan D. Knodel, Inc., a consulting firm specializing in medical device design and product development. From April 2001 until June 2005, Mr. Knodel consulted for us in product development. From 1992 to 1997, he was a principal engineer with Ethicon Endo-Surgery, a Johnson & Johnson company developing medical devices for less invasive surgery. Mr. Knodel holds B.S., M.S. and Ph.D. degrees in Mechanical Engineering from the University of Illinois.

Doug T. Ellison joined us in December 2004 as our Vice President of Sales and Marketing. From June 2004 to December 2004, Mr. Ellison consulted for medical device companies. From June 2001 until June 2004, Mr. Ellison was Vice President of Sales of Artemis Medical, Inc., a medical device company. From December 1997 until June 2001, Mr. Ellison held sales and sales management positions with Heartport, Inc., a medical device company focused on minimally-invasive cardiac surgery. Prior to Heartport, he held various positions at Guidant and C. R. Bard, Inc. Mr. Ellison holds a B.S.C.E. degree from Purdue University.

Mr. Bauer joined Cardica in July 2008 with more than 30 years of national and international operations and manufacturing experience from large healthcare organizations. Earlier in his career, he served as vice president of operations for the cardiac surgery division of Medtronic, Inc. In that position, he implemented key manufacturing processes to improve productivity and reduce costs. Prior to serving in the cardiac surgery division, he was vice president of perfusion systems for Medtronic, responsible for cardiopulmonary device manufacturing and operations. Prior to his tenure at Medtronic, he held a variety of positions at Baxter Healthcare International, including corporate vice president of operations technology, vice president of operations for drug administration and director of manufacturing services. He also previously served as president of 3RLatex, a liquid recycling company for construction sites and as general manager of Amazon Environmental, a paint recycling company. He currently serves as a member of the board of the Orange County ARC, a non-profit servicing 700 developmentally disabled adults. Mr. Bauer received his bachelor of civil engineering from the University of Detroit Mercy.

Mr. Ruedy joined Cardica in April 2007 from Abbott Vascular, where he was director of regulatory affairs for their endovascular and vessel closure business units, responsible for all regulatory operations for class II and III medical devices, including stents and stent grafts, closure devices and angioplasty catheters. He was responsible for all U.S. and international regulatory filings for these devices, and under his supervision, Abbott Vascular received two original PMA approvals in the same year. Prior to Abbott Vascular, Mr. Ruedy was vice president of regulatory, clinical and governmental affairs for Parallax Medical (acquired by ArthroCare Corporation), where he executed a corporate strategy for all domestic and international device approvals, registrations, clearances and licenses. Prior to Parallax Medical, Mr. Ruedy held escalating clinical, regulatory and quality assurance positions in multinational medical device companies, including Medtronic and Baxter Healthcare. Mr. Ruedy was also a co-founder of Acta Vascular Systems, a privately held neurovascular device company that recently merged with CardioVasc Inc. Mr. Ruedy received his bachelor of arts degree from Bucknell University.

Kevin T. Larkin has been our President, Chief Executive Officer and a member of our board of directors since May 2001. From July 1998 to April 2001, Mr. Larkin served as President and Chief Executive Officer of CardioVasc, Inc., a privately held developer and marketer of small-diameter vascular stent-grafts and accompanying treatments. From 1992 to 1997, Mr. Larkin served as Vice President of Sales and Marketing of Ventritex Inc., a publicly traded designer, developer, manufacturer and marketer of implantable defibrillators and related products for the treatment of ventricular tachycardia and ventricular fibrillation, which was acquired by St. Jude Medical in 1997. Mr. Larkin serves on the board of directors of Cardica, Inc., a publicly traded designer and manufacturer of products which automate the connections of blood vessels during coronary artery bypass graft and other grafting surgeries.

J. Michael Egan has served as director since August 2000, and served as Chairman of the Board from August 2000 until 2007. Currently, he is Chief Executive Officer of Steadman Hawkins Research Foundation, a foundation known for its research into the causes, prevention and treatment of orthopaedic disorders. From April 1996 through May 2004, Mr. Egan was President and CEO of Bluebird Development, LLC, a financial partnership with Kobayashi Pharmaceutical Company, an Osaka, Japan-based major distributor of medical devices in Asia. Mr. Egan is a director of several privately held companies and of Western Technology Investment, a registered investment company. Mr. Egan holds a B.A. degree in Business Administration from Colorado College.

Jeffrey L. Purvin joined our board in August 2006. From 2004 to July 2006, he was chairman and chief executive officer of Metrika, Inc., a disposable diabetes monitoring products company, acquired by the Bayer Group. Prior to Metrika, Mr. Purvin was president of the Interventional Products Division of Datascope Corporation, a diversified medical device company. Before Datascope, Mr. Purvin spent more than 20 years at GlaxoSmithKline, where he concluded his service as vice president, general manager. Mr. Purvin earned an MBA in marketing at The Wharton School, University of Pennsylvania and a BA in psychology from Brown University.

Stephen A. Yencho, Ph.D. has been a director since inception. Dr. Yencho co-founded Cardica in October 1997 with Dr. Hausen. From October 1997 through December 2000, Dr. Yencho was our chief executive officer. From December 2000 through July 2003, Dr. Yencho was our Chief Technology Officer, and Dr. Yencho provided consulting services to us until February 2004. Since February 2004, Dr. Yencho has been engaged in the development of early stage ventures separate from us. Dr. Yencho holds a B.S. degree in Mechanical Engineering from the University of Illinois and an M.S. degree in Manufacturing Systems Engineering from Stanford University. In addition, Dr. Yencho was sponsored by a Hewlett Packard Fellowship in the Ph.D. program in Precision Machinery Engineering at the University of Tokyo. He holds a Ph.D. degree in Materials Science and Engineering from Stanford University.